gptkbp:instanceOf
|
gptkb:drug
|
gptkbp:approvalYear
|
1997
|
gptkbp:approvedBy
|
gptkb:FDA
|
gptkbp:ATCCode
|
B01AC04
|
gptkbp:availableOn
|
gptkb:tablet
|
gptkbp:CASNumber
|
113665-84-2
|
gptkbp:chemicalFormula
|
C16H16ClNO2S
|
gptkbp:contraindication
|
severe liver impairment
active bleeding
|
gptkbp:drugClass
|
gptkb:anticoagulant
|
gptkbp:eliminationHalfLife
|
6 hours
|
gptkbp:form
|
300 mg tablet
75 mg tablet
|
gptkbp:genericName
|
gptkb:clopidogrel
|
https://www.w3.org/2000/01/rdf-schema#label
|
Plavix
|
gptkbp:interactsWith
|
gptkb:warfarin
gptkb:omeprazole
gptkb:NSAIDs
gptkb:aspirin
esomeprazole
|
gptkbp:KEGGID
|
D07710
|
gptkbp:legalStatus
|
prescription only
|
gptkbp:manufacturer
|
gptkb:Sanofi
gptkb:Bristol-Myers_Squibb
|
gptkbp:mechanismOfAction
|
P2Y12 ADP receptor inhibitor
|
gptkbp:MedlinePlusID
|
a601040
|
gptkbp:metabolism
|
liver
|
gptkbp:patentExpired
|
2012 (US)
|
gptkbp:pregnancyCategory
|
B (US)
B1 (Australia)
|
gptkbp:prescribes
|
gptkb:acute_coronary_syndrome
gptkb:peripheral_arterial_disease
recent stroke
established peripheral arterial disease
recent myocardial infarction
|
gptkbp:prescriptionStatus
|
Rx only
|
gptkbp:PubChem_CID
|
60606
CHEMBL1771
DB00758
|
gptkbp:routeOfAdministration
|
oral
|
gptkbp:sideEffect
|
diarrhea
bleeding
rash
bruising
|
gptkbp:synonym
|
gptkb:clopidogrel_bisulfate
|
gptkbp:UNII
|
44O0T30Y6D
|
gptkbp:usedFor
|
prevention of blood clots
prevention of heart attack
prevention of stroke
|
gptkbp:bfsParent
|
gptkb:Sanofi
|
gptkbp:bfsLayer
|
5
|